BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24486904)

  • 1. Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
    Nur-Nazifah M; Sabri MY; Siti-Zahrah A
    Fish Shellfish Immunol; 2014 Mar; 37(1):193-200. PubMed ID: 24486904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feed-based vaccination regime against streptococcosis in red tilapia, Oreochromis niloticus x Oreochromis mossambicus.
    Ismail MS; Siti-Zahrah A; Syafiq MR; Amal MN; Firdaus-Nawi M; Zamri-Saad M
    BMC Vet Res; 2016 Sep; 12(1):194. PubMed ID: 27608936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoglycerate kinase enhanced immunity of the whole cell of Streptococcus agalactiae in tilapia, Oreochromis niloticus.
    Wang YT; Huang HY; Tsai MA; Wang PC; Jiang BH; Chen SC
    Fish Shellfish Immunol; 2014 Dec; 41(2):250-9. PubMed ID: 25218275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
    Evans JJ; Klesius PH; Shoemaker CA
    Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-protective efficiency of feed-based whole-cell inactivated bivalent vaccine against Streptococcus and Aeromonas infections in red hybrid tilapia (Oreochromis niloticus × Oreochromis mossambicus).
    Monir MS; Yusoff MSM; Zulperi ZM; Hassim HA; Zamri-Saad M; Amal MNA; Salleh A; Mohamad A; Yie LJ; Ina-Salwany MY
    Fish Shellfish Immunol; 2021 Jun; 113():162-175. PubMed ID: 33857622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of protective antibodies and correlation with survival in Nile tilapia Oreochromis niloticus following Streptococcus agalactiae vaccination.
    Pasnik DJ; Evans JJ; Klesius PH
    Dis Aquat Organ; 2005 Sep; 66(2):129-34. PubMed ID: 16231638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemato-immunological responses and effectiveness of feed-based bivalent vaccine against Streptococcus iniae and Aeromonas hydrophila infections in hybrid red tilapia (Oreochromis mossambicus × O. niloticus).
    Monir MS; Yusoff SBM; Zulperi ZBM; Hassim HBA; Mohamad A; Ngoo MSBMH; Ina-Salwany MY
    BMC Vet Res; 2020 Jul; 16(1):226. PubMed ID: 32615969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of feed-based vaccination on tilapia farm endemic for streptococcosis.
    Ismail MS; Syafiq MR; Siti-Zahrah A; Fahmi S; Shahidan H; Hanan Y; Amal MNA; Zamri Saad M
    Fish Shellfish Immunol; 2017 Jan; 60():21-24. PubMed ID: 27864157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant lactococcal-based oral vaccine for protection against Streptococcus agalactiae infections in tilapia (Oreochromis niloticus).
    Wong KY; Megat Mazhar Khair MH; Song AAL; Masarudin MJ; Loh JY; Chong CM; Beardall J; Teo MYM; In LLA
    Fish Shellfish Immunol; 2024 Jun; 149():109572. PubMed ID: 38636739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of MONTANIDE™ GR01, a new adjuvant for feed-based vaccines, on the immune response and protection against Streptococcus agalactiae in oral vaccinated Nile tilapia (Oreochromis niloticus) under laboratory and on-farm conditions.
    Pholchamat S; Vialle R; Luang-In V; Phadee P; Wang B; Wang T; Secombes CJ; Wangkahart E
    Fish Shellfish Immunol; 2024 Jun; 149():109567. PubMed ID: 38641215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GapA, a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
    Zhang Z; Yu A; Lan J; Zhang H; Hu M; Cheng J; Zhao L; Lin L; Wei S
    Fish Shellfish Immunol; 2017 Apr; 63():255-260. PubMed ID: 28219739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of a Streptococcus agalactiae vaccine to Nile tilapia (Oreochromis niloticus) using a novel cationic-based nanoemulsion containing bile salts.
    Suwanbumrung D; Wongkhieo S; Keaswejjareansuk W; Dechbumroong P; Kamble MT; Yata T; Kitiyodom S; Rodkhum C; Thompson KD; Namdee K; Pirarat N
    Fish Shellfish Immunol; 2023 Aug; 139():108913. PubMed ID: 37393062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory responses of Nile tilapia Oreochromis niloticus to Streptococcus agalactiae: effects of vaccination and yeast diet supplement.
    Salvador R; Toazza CS; de Moraes JR; de Moraes FR
    Dis Aquat Organ; 2012 Apr; 98(3):235-41. PubMed ID: 22535873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive immunization of Nile tilapia (Oreochromis niloticus) provides significant protection against Streptococcus agalactiae.
    Pasnik DJ; Evans JJ; Klesius PH
    Fish Shellfish Immunol; 2006 Oct; 21(4):365-71. PubMed ID: 16531069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a novel Streptococcus agalactiae ghost vaccine and examination of its immunogenicity against virulent challenge in tilapia.
    Wang Q; Wang X; Wang X; Feng R; Luo Q; Huang J
    Fish Shellfish Immunol; 2018 Oct; 81():49-56. PubMed ID: 29969706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of live attenuated vaccine derived from the Streptococcus agalactiae on the immune responses of Oreochromis niloticus.
    Laith AA; Abdullah MA; Nurhafizah WWI; Hussein HA; Aya J; Effendy AWM; Najiah M
    Fish Shellfish Immunol; 2019 Jul; 90():235-243. PubMed ID: 31009810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a vaccine against Streptococcus agalactiae in fish based on truncated cell wall surface anchor proteins.
    Liu H; Zhang S; Shen Z; Ren G; Liu L; Ma Y; Zhang Y; Wang W
    Vet Rec; 2016 Oct; 179(14):359. PubMed ID: 27660279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Streptococcus agalactiae vaccines for tilapia.
    Liu G; Zhu J; Chen K; Gao T; Yao H; Liu Y; Zhang W; Lu C
    Dis Aquat Organ; 2016 Dec; 122(2):163-170. PubMed ID: 28000606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): Insight into vaccine development.
    Li W; Wang HQ; He RZ; Li YW; Su YL; Li AX
    Fish Shellfish Immunol; 2016 Aug; 55():737-46. PubMed ID: 27327442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
    Wang Q; Fu T; Li X; Luo Q; Huang J; Sun Y; Wang X
    Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.